Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 132

Sort by

Sort Order Select

Journal Articles

Survival Impact of Early Versus Late Discontinuation of Immunosuppression after Allogeneic Stem Cell Transplantation

Justin Laporte, Katelin Jackson, Xu Zhang, Asad Bashey, Lawrence E Morris, Lizamarie Bachier Rodriguez, Melhem M. Solh, Scott R. Solomon, H. Kent Holland

Blood (2024) 144 (Supplement 1): 7333.

https://doi.org/10.1182/blood-2024-200207

Published: 2024

Journal Articles

Safety and Efficacy of Ibrutinib Added to Rituximab-Based Primary Therapy of Chronic Graft-Versus-Host-Disease

Scott R. Solomon, Melissa Sanacore, Lizamarie Bachier Rodriguez, Latasha McCoy, Caitlin Guzowski, Katelin C Jackson, Xu Zhang, H. Kent Holland, Lawrence E Morris, Melhem M. Solh, Asad Bashey

Blood (2024) 144 (Supplement 1): 3528.

https://doi.org/10.1182/blood-2024-199618

Published: 2024

Journal Articles

Association of Hematocrit and Platelet Values Post RBC Exchange (RCE) with Vaso-Occlusive Complications in Sickle Cell Disease (SCD)

Insia Rizvi, Victor R. Gordeuk, Xu Zhang, Robert Molokie, David Allison, Sally Campbell Lee, Marwah Farooqui

Blood (2024) 144 (Supplement 1): 5363.

https://doi.org/10.1182/blood-2024-206189

Published: 2024

Journal Articles

The Degree of HLA-DPB1 Mismatch Predicted By Evolutionary Divergence Scoring Informs the Risk of Chronic Graft-Versus-Host Disease after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Melhem M. Solh, Asad Bashey, Michael T Aubrey, Brian Freed, Christina Roark, Lawrence E Morris, H Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Scott R. Solomon

Blood (2024) 144 (Supplement 1): 4913.

https://doi.org/10.1182/blood-2024-210329

Published: 2024

Journal Articles

Extracorporeal Photopheresis (ECP) in the Era of New Chronic Graft-Versus-Disease (GVHD) Therapies

Melhem M. Solh, Asad Bashey, Lawrence E Morris, Lizamarie Bachier-Rodriguez, H. Kent Holland, Xu Zhang, Rajveer Singh, Katelin Jackson, Scott R. Solomon

Blood (2024) 144 (Supplement 1): 4912.

https://doi.org/10.1182/blood-2024-208659

Published: 2024

Journal Articles

Polatuzumab Vedotin, Rituximab and Lenalidomide (Pola-R 2 ) As First-Line Therapy for Unfit and Frail Elderly Diffuse Large B-Cell Lymphoma Patients: Preliminary Result of a Prospective, Phase II, Multi-Center Study

Wei Wang, Xu Zhang, Qihui Li, Hua Yin, Xiubin Xiao, Jian Li, Wenrong Huang, Hongmei Jing, Yan Zhang

Blood (2024) 144 (Supplement 1): 1728.

https://doi.org/10.1182/blood-2024-198294

Published: 2024

Journal Articles

Improved Outcomes of Adult Patients with Philadelphia-like Acute Lymphoblastic Leukemia (Ph-Like ALL) Treated within an Integrated Leukemia/Transplant Program with Incorporation of Pediatric Inspired Regimens and Early Allogeneic Transplant

Asad Bashey, Xu Zhang, H. Kent Holland, Lawrence E Morris, Lizamarie Bachier-Rodriguez, Scott R. Solomon, Melhem M. Solh

Blood (2024) 144 (Supplement 1): 1450.

https://doi.org/10.1182/blood-2024-209117

Published: 2024

Journal Articles

Comparison of FLAG-Idarubicin to FLAG-Idarubicin Plus Venetoclax for Treatment of Newly Diagnosed AML in Patients Eligible for Intensive Induction. Analysis of 200 Consecutive Patients Treated at a Single Center

Asad Bashey, Xu Zhang, Lawrence E Morris, H. Kent Holland, Lizamarie Bachier-Rodriguez, Scott R. Solomon, Melhem M. Solh

Blood (2024) 144 (Supplement 1): 1522.

https://doi.org/10.1182/blood-2024-209199

Published: 2024

Journal Articles

Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis

Teng Xu, Xu Zhang, Wenting Zhao, Jiaxin Shi, Sitong Wan, Yan Zhang, Yanling Hao, Mingyue Sun, Jingjing He, Li Jiang, Hao Wang, Hong Gao, Junjie Luo, Yongting Luo, Peng An

Blood (2024) 144 (12): 1314–1328.

https://doi.org/10.1182/blood.2024024293

Published: 2024

Includes: Supplemental data

Journal Articles

Impact of Allograft T-Cell (CD3) Dose on Outcomes When CD34 Cell Dose Is Capped: Analysis of 811 Consecutive Allogeneic PBSC Transplants from a Single Center

Asad Bashey, Xu Zhang, Lawrence Morris, Kent Holland, Lizamarie Bachier-Rodriguez, Melhem M. Solh, Scott R. Solomon

Blood (2023) 142 (Supplement 1): 2182.

https://doi.org/10.1182/blood-2023-180383

Published: 2023

Journal Articles

Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity

Melhem M. Solh, Asad Bashey, Lawrence Morris, Lizamarie Bachier-Rodriguez, H Kent Holland, Xu Zhang, Katelin C Jackson, Scott R. Solomon

Blood (2023) 142 (Supplement 1): 2138.

https://doi.org/10.1182/blood-2023-186585

Published: 2023

Journal Articles

Impact of an HLA-DPB1 Non-Permissive Mismatch By the Revised T Cell Epitope (TCE)-Core Algorithm on Survival Following Haploidentical Donor Transplantation (HIDT) with Post-Transplant Cyclophosphamide (PTCy)

Scott R. Solomon, Michael T Aubrey, Lizamarie Bachier-Rodriguez, Melhem M. Solh, Katelin C Jackson, Xu Zhang, Christina Roark, H. Kent Holland, Lawrence Morris, Asad Bashey

Blood (2023) 142 (Supplement 1): 2240.

https://doi.org/10.1182/blood-2023-182499

Published: 2023

Journal Articles

Compared to Venetoclax Plus Hypomethylating Agents, High Dose Cytarabine Based Intensive Chemotherapy Induction for Newly Diagnosed Acute Myeloid Leukemia (AML) Leads to a Faster Remission Resulting in Better Survival

Melhem M. Solh, Scott R. Solomon, Lawrence Morris, H Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Katelin C Jackson, Asad Bashey

Blood (2023) 142 (Supplement 1): 2896.

https://doi.org/10.1182/blood-2023-186117

Published: 2023

Journal Articles

Impact of HLA-DQ Heterodimer Group (G1/G2) Mismatch on Relapse and Survival Following Haploidentical Donor Transplantation

Scott R. Solomon, Michael T Aubrey, Xu Zhang, Lizamarie Bachier-Rodriguez, Lawrence Morris, H. Kent Holland, Christina Roark, Katelin C Jackson, Asad Bashey, Melhem M. Solh

Blood (2023) 142 (Supplement 1): 4984.

https://doi.org/10.1182/blood-2023-182503

Published: 2023

Journal Articles

Immunosuppression Free at One-Year Post Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY)

Melhem M. Solh, Scott R. Solomon, Lawrence Morris, Lizamarie Bachier-Rodriguez, H Kent Holland, Xu Zhang, Katelin C Jackson, Asad Bashey

Blood (2023) 142 (Supplement 1): 4945.

https://doi.org/10.1182/blood-2023-187505

Published: 2023

Journal Articles

Menopause in Sickle Cell Disease: Unchartered Territory

Marwah Farooqui, Elisa Martinez, Kaitlin Sung, Marianna Vakaki, Kayla Gross, Xu Zhang, Victor R. Gordeuk, Gelila Goba

Blood (2023) 142 (Supplement 1): 2509.

https://doi.org/10.1182/blood-2023-189968

Published: 2023

Journal Articles

Steady-State Von Willebrand Factor Antigen Levels Predict Low Platelet Counts and Risk for Complications in Hospitalizations for Painful Sickle Cell Vaso-Occlusive Episodes

Xu Zhang, Binal Shah, Jin Han, Jose A. Lopez, Dominic W. Chung, Junmei Chen, Victor R. Gordeuk, Santosh L. Saraf

Blood (2023) 142 (Supplement 1): 2483.

https://doi.org/10.1182/blood-2023-190297

Published: 2023

Journal Articles

Alkaline Phosphatase As a Marker for Acute Complications in Sickle Cell Disease

Jin Han, Xu Zhang, Binal Shah, Santosh L. Saraf, Victor R. Gordeuk

Blood (2023) 142 (Supplement 1): 3683.

https://doi.org/10.1182/blood-2023-174807

Published: 2023

Journal Articles

Comparison of Condensed to Standard Schedule of High Dose Cytarabine Consolidation for Acute Myeloid Leukemia in First Complete Remission

Melhem M. Solh, Kristen Kilby, Jimena Baron, Xu Zhang, Asad Bashey, H Kent Holland, Lizamarie Bachier-Rodriguez, Lawrence Morris, Scott R. Solomon

Blood (2023) 142 (Supplement 1): 5939.

https://doi.org/10.1182/blood-2023-186662

Published: 2023

Journal Articles

Post-Transplant Maintenance in AML and MDS Patients Undergoing Non-Myeloablative Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide

Lan Lei, Asad Bashey, Scott R. Solomon, Lawrence Morris, H Kent Holland, Melhem M. Solh, Katelin C Jackson, Xu Zhang, Lizamarie Bachier Rodriguez

Blood (2023) 142 (Supplement 1): 6968.

https://doi.org/10.1182/blood-2023-190663

Published: 2023

NARROW

Survival Impact of Early Versus Late Discontinuation of Immunosuppression after Allogeneic Stem Cell Transplantation

Safety and Efficacy of Ibrutinib Added to Rituximab-Based Primary Therapy of Chronic Graft-Versus-Host-Disease

Association of Hematocrit and Platelet Values Post RBC Exchange (RCE) with Vaso-Occlusive Complications in Sickle Cell Disease (SCD)

The Degree of HLA-DPB1 Mismatch Predicted By Evolutionary Divergence Scoring Informs the Risk of Chronic Graft-Versus-Host Disease after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Extracorporeal Photopheresis (ECP) in the Era of New Chronic Graft-Versus-Disease (GVHD) Therapies

Polatuzumab Vedotin, Rituximab and Lenalidomide (Pola-R 2 ) As First-Line Therapy for Unfit and Frail Elderly Diffuse Large B-Cell Lymphoma Patients: Preliminary Result of a Prospective, Phase II, Multi-Center Study

Improved Outcomes of Adult Patients with Philadelphia-like Acute Lymphoblastic Leukemia (Ph-Like ALL) Treated within an Integrated Leukemia/Transplant Program with Incorporation of Pediatric Inspired Regimens and Early Allogeneic Transplant

Comparison of FLAG-Idarubicin to FLAG-Idarubicin Plus Venetoclax for Treatment of Newly Diagnosed AML in Patients Eligible for Intensive Induction. Analysis of 200 Consecutive Patients Treated at a Single Center

Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis

Impact of Allograft T-Cell (CD3) Dose on Outcomes When CD34 Cell Dose Is Capped: Analysis of 811 Consecutive Allogeneic PBSC Transplants from a Single Center

Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity

Impact of an HLA-DPB1 Non-Permissive Mismatch By the Revised T Cell Epitope (TCE)-Core Algorithm on Survival Following Haploidentical Donor Transplantation (HIDT) with Post-Transplant Cyclophosphamide (PTCy)

Compared to Venetoclax Plus Hypomethylating Agents, High Dose Cytarabine Based Intensive Chemotherapy Induction for Newly Diagnosed Acute Myeloid Leukemia (AML) Leads to a Faster Remission Resulting in Better Survival

Impact of HLA-DQ Heterodimer Group (G1/G2) Mismatch on Relapse and Survival Following Haploidentical Donor Transplantation

Immunosuppression Free at One-Year Post Haploidentical Hematopoietic Cell Transplantation (Haplo) with Post-Transplant Cyclophosphamide (PTCY)

Menopause in Sickle Cell Disease: Unchartered Territory

Steady-State Von Willebrand Factor Antigen Levels Predict Low Platelet Counts and Risk for Complications in Hospitalizations for Painful Sickle Cell Vaso-Occlusive Episodes

Alkaline Phosphatase As a Marker for Acute Complications in Sickle Cell Disease

Comparison of Condensed to Standard Schedule of High Dose Cytarabine Consolidation for Acute Myeloid Leukemia in First Complete Remission

Post-Transplant Maintenance in AML and MDS Patients Undergoing Non-Myeloablative Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only